Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Bertoletti

Showing results (51-60 of 224) with videos related to

Pageof 23
Sort By:
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2025
mRNA-Based Engineering of Viral Antigen-Specific TCR-T CellsHe Shan, Antonio Bertoletti, Anthony Tanoto Tan
Seminars in Immunology|November 7, 2025
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectivenessShan He, Anthony T Tan, Antonio Bertoletti
Intervirology|July 19, 2014
Host factor-targeted hepatitis B virus therapiesAdam Gehring, Antonio Bertoletti, John E Tavis
The Journal of Clinical Investigation|December 15, 2021
Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. ReplyAnthony T Tan, Nina Le Bert, Antonio Bertoletti
International Journal of Molecular Sciences|September 23, 2022
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue LocalizationAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Oxford Open Immunology|April 16, 2024
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective roleAntonio Bertoletti, Anthony T Tan, Nina Le Bert
Gut|December 3, 2017
HBV infection and HCC: the 'dangerous liaisons'Antonio Bertoletti, Patrick T F Kennedy, David Durantel
Viruses|October 14, 2011
HBV-Specific Adaptive ImmunityAntonio Bertoletti, Anthony T Tan, Adam J Gehring
Immunity|September 1, 2022
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemicAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Journal of Gastroenterology and Hepatology|June 21, 2008
Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospectiveAnthony Tanoto Tan, Sarene Koh, Vera Goh, et al.
Pageof 23

Showing results (51-60 of 224) with videos related to

Sort By:
Pageof 23
Methods in Molecular Biology (Clifton, N.J.)|August 28, 2025
mRNA-Based Engineering of Viral Antigen-Specific TCR-T CellsHe Shan, Antonio Bertoletti, Anthony Tanoto Tan
Seminars in Immunology|November 7, 2025
HBV antigen as a tumour antigen in adoptive TCR-T cell therapy for HBV-related HCC: rationale and clinical effectivenessShan He, Anthony T Tan, Antonio Bertoletti
Intervirology|July 19, 2014
Host factor-targeted hepatitis B virus therapiesAdam Gehring, Antonio Bertoletti, John E Tavis
The Journal of Clinical Investigation|December 15, 2021
Difference in sensitivity between SARS-CoV-2-specific T cell assays in patients with underlying conditions. ReplyAnthony T Tan, Nina Le Bert, Antonio Bertoletti
International Journal of Molecular Sciences|September 23, 2022
Act Early and at the Right Location: SARS-CoV-2 T Cell Kinetics and Tissue LocalizationAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Oxford Open Immunology|April 16, 2024
The T-cell response to SARS-CoV-2: kinetic and quantitative aspects and the case for their protective roleAntonio Bertoletti, Anthony T Tan, Nina Le Bert
Gut|December 3, 2017
HBV infection and HCC: the 'dangerous liaisons'Antonio Bertoletti, Patrick T F Kennedy, David Durantel
Viruses|October 14, 2011
HBV-Specific Adaptive ImmunityAntonio Bertoletti, Anthony T Tan, Adam J Gehring
Immunity|September 1, 2022
SARS-CoV-2-specific T cells in the changing landscape of the COVID-19 pandemicAntonio Bertoletti, Nina Le Bert, Anthony T Tan
Journal of Gastroenterology and Hepatology|June 21, 2008
Understanding the immunopathogenesis of chronic hepatitis B virus: an Asian prospectiveAnthony Tanoto Tan, Sarene Koh, Vera Goh, et al.
Pageof 23